What is Rxsight Inc (RXST) stock price today?

Rxsight Inc (RXST) currently trades at $6.81 per share. The stock has a market capitalization of $295.88M and a P/E ratio of —x.

Is RXST stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Rxsight Inc has a Smart Value Score of 29/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Rxsight Inc's revenue and earnings?

Rxsight Inc has trailing twelve-month (TTM) revenue of $134.48M with profit margins of -29.00%. Earnings per share (EPS) is $-0.95.

Is RXST stock overvalued or undervalued?

Based on our DCF model, Rxsight Inc's intrinsic value is $30.01, representing a margin of safety of 73.24%. The stock currently trades at a P/E of —x.

RXST

Rxsight Inc

NASDAQ: RXST · HEALTHCARE · MEDICAL DEVICES

$6.81

-5.02% today

Updated 2026-04-29

Market cap

$295.88M

P/E ratio

—

P/S ratio

2.20x

EPS (TTM)

$-0.95

Dividend yield

—

52W range

$6 – $17

Volume

0.7M

Market cap

$295.88M

P/E ratio

—

P/S ratio

2.20x

EPS (TTM)

$-0.95

Dividend yield

—

52W range

$6 – $17

Volume

0.7M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$9.93

+45.81%

12-Month target

—

Intrinsic (DCF)

$30.01

Margin of safety

+73.24%

1 Strong Buy0 Buy6 Hold0 Sell2 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ 73.24% below intrinsic value

Risks

- Thin margins at -29.00%

- Negative free cash flow $-3.81M

- Revenue declining -18.90% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$49.01M	$89.08M	$139.93M	$134.48M	$134.48M
Net income	$-66.76M	$-48.61M	$-27.45M	$-38.94M	$-9.15M
EPS	—	—	—	—	$-0.95
Free cash flow	$-61.24M	$-46.41M	$-22.39M	$-19.34M	$-3.81M
Profit margin	-136.22%	-54.57%	-19.62%	-28.96%	-29.00%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
RXST	$295.88M	29	5.3	2.0	6.7	5.0	+73.24%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Rxsight Inc trades at $6.81. Our Smart Value Score of 29/100 indicates the stock is weak. TTM revenue stands at $134.48M. with profit margins at -29.00%. Our DCF model estimates intrinsic value at $30.01.

Frequently asked questions

What is Rxsight Inc's stock price?

Rxsight Inc (RXST) trades at $6.81.

Is Rxsight Inc overvalued?

Smart Value Score 29/100 (Grade F, Strong Sell). DCF value $30.01.

What is the price target of Rxsight Inc (RXST)?

The analyst target price is $9.93, representing +45.8% upside from the current price of $6.81.

What is the intrinsic value of Rxsight Inc (RXST)?

Based on our DCF model, intrinsic value is $30.01, a +73.2% margin of safety versus $6.81.

What is Rxsight Inc's revenue?

TTM revenue is $134.48M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.20x

ROE-14.00%

Beta1.21

50D MA$7.34

200D MA$8.78

Shares out0.04B

Float0.04B

Short ratio—

Avg volume0.7M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

RXST vs LLY →RXST vs JNJ →RXST vs ABBV →Stock screener →